Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
L'Encephale|May 1, 1996
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]B Bonin, G Bertschy, P Baumann, et al.
Neuropsychobiology|January 1, 1992
Tricyclic antidepressant plasma levels after fluoxetine additionS Vandel, G Bertschy, B Bonin, et al.
Psychopharmacology|January 1, 1986
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsM F Poirier, C Benkelfat, H Loo, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|May 1, 1983
[Computerized quantitative topo-electroencephalography]B Pidoux, P Etevenon, D Campistron, et al.
Therapeutic Drug Monitoring|December 29, 2000
Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluationM Gex-Fabry, E Haffen, G Paintaud, et al.
British Journal of Clinical Pharmacology|February 1, 1989
Substantial rise in sparteine metabolic ratio during haloperidol treatmentL F Gram, D Debruyne, V Caillard, et al.
Revue D'Epidemiologie Et De Sante Publique|January 26, 2006
[Neuroleptic drug utilization among schizophrenic outpatients]P Blin, J-P Olié, D Sechter, et al.
L'Encephale|January 1, 1983
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor]M F Poirier, J P Olié, H Lôo, et al.
Therapie|January 1, 1995
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]P Vandel, P Bizouard, S Vandel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1994
Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophreniaJ M Leroux, E Elia, M Jacquet, et al.
Pageof 16